EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Application Spinal Chord Stimulation (SCS) for management Tromboangiitis obliterans (Burger disease). Clinical observation study

V Ya Babchenko, R S Kiselev, V I Murtazin

Neurochirurgie · 2026-05 · 72 (3) · 101796

DOI: 10.1016/j.neuchi.2026.101796 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Neurochirurgie, 2026-05. Verfasst von V Ya Babchenko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Meshalkin National Medical Research Centre, Novosibirsk, 630055, Russia. Electronic address: v.babchenko@alumni.nsu.ru. Hauptthemen laut MEDLINE: Thromboangiitis Obliterans, Spinal Cord Stimulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES This study aimed to evaluate the efficacy of spinal cord stimulation (SCS) in improving tissue perfusion and functional outcomes in patients with thromboangiitis obliterans (TAO), while assessing its impact on ulcer healing and amputation rates. METHODS This single-center retrospective study analyzed 10 TAO patients undergoing SCS implantation (2015-2024). Perfusion parameters (TcPO₂, LDF) were assessed at rest and during orthostatic test, with pain-free walking distance measured pre- and postoperatively. Inclusion required Fontaine stage ≥ IIb, failed revascularization/conservative therapy, and efficient trial stimulation (≥50% VAS reduction or ≥20% walking distance improvement). RESULTS SCS implantation yielded significant improvements across multiple parameters. Pain-free walking distance increased by 264.5% (p = 0.05), while tissue perfusion showed differential enhancement: resting TcPO₂ improved by 68.5% (p = 0.5) with stable LDF values (p = 0.39), whereas orthostatic testing demonstrated 39.5% TcPO₂ (p = 0.46) and 39.5% LDF (p = 0.42) improvements. Fontaine stage improved in 60% of patients, with 80% ulcer healing and 10% amputation rates observed during follow-up. CONCLUSION Spinal cord stimulation shows promise as a safe and effective treatment for thromboangiitis obliterans, improving walking capacity, tissue perfusion, and ulcer healing while reducing amputation rates. These findings support SCS as a viable therapeutic option for TAO patients unresponsive to standard therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thromboangiitis ObliteransSpinal Cord StimulationHumansFemaleMaleRetrospective StudiesMiddle AgedTreatment OutcomeAgedAdult

Stichwörter der Autor:innen

Buerger's diseaseSCSSpinal cord stimulationThromboangiitis obliterans

Autor:innen und Institutionen

  • Department of Neurosurgery, Meshalkin National Medical Research Centre, Novosibirsk, 630055, Russia. Electronic address: v.babchenko@alumni.nsu.ru.
  • Department of Neurosurgery, Meshalkin National Medical Research Centre, Novosibirsk, 630055, Russia. Electronic address: kiselevphd@gmail.com.
  • Department of Neurosurgery, Meshalkin National Medical Research Centre, Novosibirsk, 630055, Russia. Electronic address: neurovladimir@gmail.com.

Zitieren

APA

Babchenko, V. Y., Kiselev, R. S., & Murtazin, V. I. (2026). Application Spinal Chord Stimulation (SCS) for management Tromboangiitis obliterans (Burger disease). Clinical observation study. Neurochirurgie, 72(3), 101796. https://doi.org/10.1016/j.neuchi.2026.101796

Vancouver

Babchenko VY, Kiselev RS, Murtazin VI. Application Spinal Chord Stimulation (SCS) for management Tromboangiitis obliterans (Burger disease). Clinical observation study. Neurochirurgie. 2026;72(3):101796. doi:10.1016/j.neuchi.2026.101796

BibTeX
@article{Babchenko2026,
  author = {Babchenko, V Ya and Kiselev, R S and Murtazin, V I},
  title = {Application Spinal Chord Stimulation (SCS) for management Tromboangiitis obliterans (Burger disease). Clinical observation study},
  journal = {Neurochirurgie},
  year = {2026},
  volume = {72},
  number = {3},
  pages = {101796},
  doi = {10.1016/j.neuchi.2026.101796}
}
Kostenlos starten →